Lung cancer rehab study aims to pinpoint what really matters for patients
NCT ID NCT07434947
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will enroll 63 people with advanced non-small cell lung cancer whose disease has been stable for at least 6 months. Participants will take part in a 3-month rehabilitation program that includes physical activity. Researchers will measure quality of life, hand grip strength, and a sit-to-stand test to see which outcomes best capture the benefits of rehab. The goal is to identify the most useful measures for future studies comparing different rehabilitation approaches.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
rehabilitation program (physical activity)
What this could lead to
If successful, this study could identify the best way to measure whether rehabilitation helps people with advanced lung cancer feel stronger and have a better quality of life.
What could go wrong
This is a small, early-stage study (63 participants) that is not yet recruiting. It is designed to find the right measurement tools, not to prove that rehabilitation works, so results may not lead to immediate changes in care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
CH Métropole Savoie
Chambéry, Chambéry, 73 100, France
Contact Email: •••••@•••••
Contact
-
CHU Grenoble Alpes
Grenoble, 38043, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
-
Centre Hospitalier Annecy Genevois
Annecy, 74370, France
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Contact